Asthma Drugs Market to Reach USD 41.18 Billion by 2035 | Biologic Therapies Accelerate Shift Toward Targeted Treatment ...
High-value biologic therapies are overtaking traditional treatments, driving revenue despite pricing pressures on standard inhalers. The market is bifurcating, with innovation focused on severe phenotypes and smart delivery, while policy shifts mandate …